SureTrader SureTrader
Home > Boards > US OTC > Biotechs > RespireRx Pharmaceuticals Inc. (RSPI)

If no one can make a safe ampakine

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
sparkyone Member Profile
 
Followed By 0
Posts 616
Boards Moderated 0
Alias Born 05/06/08
160x600 placeholder
RespireRx Pharmaceuticals Inc. Files September 30, 2016 Quarterly Report on Form 10-Q "Marketwired" - 11/15/2016 6:04:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/15/2016 3:08:01 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 11/15/2016 2:50:56 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/1/2016 9:02:11 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/31/2016 4:17:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/17/2016 4:24:58 PM
RespireRx Pharmaceuticals Inc. to Present at the BIO Investor Forum on Tuesday, October 18, 2016 at the St. Francis Hotel in ... "Marketwired" - 10/17/2016 8:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/7/2016 4:46:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/4/2016 4:46:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/28/2016 5:05:26 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/28/2016 6:05:55 AM
UPDATE - RespireRx Pharma Announces Preliminary Top-Line Analysis of Data From Duke University Phase 2A Clinical Trial of CX1... "Marketwired" - 9/12/2016 8:02:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/12/2016 9:13:02 AM
RespireRx Pharma. Announces Preliminary Top-Line Analysis of Data From Duke University Phase 2A Clinical Trial of CX1739 "Marketwired" - 9/12/2016 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/1/2016 4:32:36 PM
RespireRx Pharmaceuticals Inc. Announces 1-for-325 Reverse Stock Split "Marketwired" - 9/1/2016 4:15:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/22/2016 8:31:52 AM
RespireRx Pharmaceuticals Inc. Files June 30, 2016 Quarterly Report on Form 10-Q "Marketwired" - 8/15/2016 8:30:00 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 8/12/2016 11:05:13 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/12/2016 8:36:06 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/19/2016 5:53:12 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/13/2016 8:34:11 AM
RespireRx Pharmaceuticals Inc. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference on July 13, 2016 "Marketwired" - 7/12/2016 10:42:00 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 7/8/2016 11:40:52 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2016 7:55:00 PM
sparkyone   Wednesday, 05/16/12 07:34:12 AM
Re: None
Post # of 39779 
If no one can make a safe ampakine why would anyone take the risk?
Why risk a career? Why waste the money?

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist